Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Equity (2016 - 2025)

Historic Return on Equity for Ocular Therapeutix (OCUL) over the last 12 years, with Q4 2025 value amounting to 0.58%.

  • Ocular Therapeutix's Return on Equity fell 800.0% to 0.58% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.58%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.54% for FY2025, which is 2700.0% up from last year.
  • Ocular Therapeutix's Return on Equity amounted to 0.58% in Q4 2025, which was down 800.0% from 0.88% recorded in Q3 2025.
  • In the past 5 years, Ocular Therapeutix's Return on Equity registered a high of 0.3% during Q2 2024, and its lowest value of 16.05% during Q3 2023.
  • Over the past 5 years, Ocular Therapeutix's median Return on Equity value was 0.94% (recorded in 2021), while the average stood at 2.49%.
  • Examining YoY changes over the last 5 years, Ocular Therapeutix's Return on Equity showed a top increase of 1244500bps in 2021 and a maximum decrease of -329600bps in 2021.
  • Ocular Therapeutix's Return on Equity (Quarter) stood at 0.97% in 2021, then plummeted by -115bps to 2.08% in 2022, then grew by 13bps to 1.81% in 2023, then surged by 73bps to 0.49% in 2024, then decreased by -17bps to 0.58% in 2025.
  • Its last three reported values are 0.58% in Q4 2025, 0.88% for Q3 2025, and 0.78% during Q2 2025.